Structure Therapeutics Inc.
GPCR
$32.76
-$0.56-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.17% | -46.73% | -36.72% | -43.59% | -53.23% |
| Total Depreciation and Amortization | 76.84% | 123.93% | 215.19% | 173.91% | 114.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 205.67% | 552.48% | -32.28% | -48.05% | -42.16% |
| Change in Net Operating Assets | 299.73% | 24.88% | -57.45% | 63.61% | -291.77% |
| Cash from Operations | -58.57% | -44.53% | -46.73% | -46.02% | -72.10% |
| Capital Expenditure | 51.38% | 38.09% | 40.47% | -124.58% | -667.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.61% | -50.69% | -34.35% | -648.87% | -183.85% |
| Cash from Investing | 79.41% | -49.74% | -33.75% | -641.53% | -185.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.69% | 71.55% | 9.29% | 372.06% | 373.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.97% | 90.83% | 91.67% | -497.82% | -419.70% |
| Cash from Financing | -99.85% | 82.43% | 14.11% | 369.54% | 372.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.79% | 289.42% | -61.70% | 438.92% | 2,389.14% |